[1]魏丽琼,赵蓉蓉,田一虹,等.miR-34a-5p在胃癌细胞和胃癌组织中的表达及其靶基因信号通路富集分析[J].甘肃中医药大学学报,2018,35(06):1-6.[doi:10.16841/j.issn1003-8450.2018.06.01]
 WEI Liqiong,ZHAO Rongrong,TIAN Yihong,et al.Expression of miR-34a-5p in gastric cancer cells and tissues and analysis of signaling pathway enrichment of target genes[J].Journal of Gansu University of Chinese Medicine,2018,35(06):1-6.[doi:10.16841/j.issn1003-8450.2018.06.01]
点击复制

miR-34a-5p在胃癌细胞和胃癌组织中的表达及其靶基因信号通路富集分析
分享到:

《甘肃中医药大学学报》[ISSN:1003-8450/CN:62-1062/R]

卷:
35卷
期数:
2018年06期
页码:
1-6
栏目:
论著
出版日期:
2018-12-25

文章信息/Info

Title:
Expression of miR-34a-5p in gastric cancer cells and tissues and analysis of signaling pathway enrichment of target genes
作者:
魏丽琼1 赵蓉蓉2 田一虹3 呼永华3 李海龙3 刘月芬1
1. 甘肃省妇幼保健院儿童保健科, 甘肃 兰州 730050;
2. 甘肃中医药大学附属医院检验科, 甘肃 兰州 730020;
3. 甘肃中医药大学临床医学院, 甘肃 兰州 730000
Author(s):
WEI Liqiong1 ZHAO Rongrong2 TIAN Yihong3 HU Yonghua3 LI Hailong3 LIU Yuefen1
1. Child Health Department, Gansu Maternal and Child Health Hospital, Lanzhou, Gansu, 730050, China;
2. Clinical Laboratory, Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, Gansu, 730020, China;
3. Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, Gansu, 730000, China
关键词:
胃癌miR-34a-5p分子标志物表达
Keywords:
gastric cancermiR-34a-5pmolecular markerexpression
分类号:
R735.2;R730.231
DOI:
10.16841/j.issn1003-8450.2018.06.01
摘要:
目的 研究胃癌细胞和胃癌组织中miR-34a-5p的表达,分析其临床意义,并采用生物信息学方法进行miR-34a-5p靶基因预测和信号通路富集分析。方法 采用实时荧光定量聚合酶链反应(PCR)检测miR-34a-5p在不同分化程度的胃癌细胞和正常胃黏膜上皮细胞中的表达以及在胃癌组织和癌旁组织中的表达,比较并分析其临床意义;采用miRWalk网站的生物信息学软件预测miR-34a-5p的靶基因,采用DAVID 6.7软件对靶基因进行信号通路富集聚类分析。结果 与正常胃黏膜上皮细胞比较,miR-34a-5p在胃癌细胞HGC-27、SGC-7901中的相对表达量未明显上调,差异均无统计学意义(P>0.05),在胃癌细胞MKN-45、MKN-28、MGC-803、BGC-823、AGS中的相对表达量均明显上调,差异有统计学意义(P<0.05或P<0.01);与癌旁组织比较,miR-34a-5p在胃癌组织中有32例表达上调[2.79(1.91,5.78)],18例表达下调[0.37(0.14,0.45)],差异有统计学意义(Z=5.821,P=0.000),提示miR-34a-5p在胃癌组织中以高表达为主;在胃癌组织中,miR-34a-5p的高表达与胃癌分化程度、淋巴结转移具有相关性(P<0.05);生物信息学分析结果提示,miR-34a-5p的靶基因富集在与肿瘤相关的28个信号通路中。结论 miR-34a-5p是胃癌的高表达分子标志物,是潜在的具有临床相关性的癌基因。
Abstract:
Objective To observe the expression of miR-34a-5p in gastric cancer cells and tissues and analyze its clinical significance;to predict the target genes and analyze the signaling pathway enrichment using bioinforma-tics methods. Methods Real-time fluorescence quantitative PCR was used to detect the expression of miR-34a-5p in gastric cancer cells with different degrees of differentiation and in the normal gastric epithelial cells, and in cancerous and paracancerous gastric tissues, we made comparisons and analyzed the clinical significance. The bioinformatics software in miRWalk website was used to predict the target genes of miR-34a-5p and the software DAVID 6.7 was used to cluster analyze the signaling pathway enrichment of target genes. Results Compared with the normal gastric epithelial cells, the relative expression quantity of miR-34a-5p in gastric cancer cells HGC-27 and SGC-7901 was not significantly up-regulated, there was no statistically significant difference (P>0.05), while it all up-regulated significantly in gastric cancer cells MKN-45, MKN-28, MGC-803, BGC-823 and AGS, there were statistically significant differences (P<0.05 or P<0.01);compared with paracancerous gastric tissues, the expression of miR-34a-5p up-regulated in 32 cases of gastric cancer tissues[2.79 (1.91, 5.78)], down-regulated in 18 cases[0.37 (0.14, 0.45)], there was statistically significant difference (Z=5.821, P=0.000), which suggested that miR-34a-5p was highly expressed in gastric cancer tissues;in gastric cancer tissues, the high expression of miR-34a-5p was correlated with the degrees of differentiation and lymph node metastasis of gastric cancer (P<0.05);the analysis results of bioinformatics suggested that the target genes of miR-34a-5p enriched in 28 signaling pathways related to tumors.Conclusion miR-34a-5p is a highly expressed molecular marker in gastric cancer and is a potentially clinically relevant oncogene.

参考文献/References:

[1] ZHANG Z, KONG Y, YANG W, et al.Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET[J].Oncology reports, 2016, 36(4):2391-2397.
[2] Hwang H W, Mendell J T.MicroRNAs in cell proliferation, cell death, and tumorigenesis[J].British Journal of Cancer, 2007, 96:40-44.
[3] Hata A, Kashima R.Dysregulation of microRNA biogenesis machinery in cancer[J].Critical Reviews in Biochemistry and Molecular Biology, 2016, 51(3):121-134.
[4] Tsai M M, Wang C S, Tsai C Y, et al.Potential diagnostic, prognostic and therapeutic targets of microRNAs in human gastric cancer[J].International Journal of Molecular Sciences, 2016, 17(6):36.
[5] YAO Y, SUO A L, LI Z F, et al.MicroRNA profiling of human gastric cancer[J]. Molecular Medicine Reports, 2009, 2(6):963-970.
[6] Pogribny I P, Tryndyak V P, Boyko A, et al.Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure[J].Mutation Research, 2007, 619(1/2):30-37.
[7] Sukata T, Sumida K, Kushida M, et al.Circulating micro-RNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages[J].Toxicology letters, 2011, 200(1/2):46-52.
[8] WANG M, ZHANG P, LI Y, et al.The quantitative analysis by stem-loop real-time PCR revealed the micro-RNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer[J].Medical Oncology(Northwood, London, England), 2012, 29(5):3113-3118.
[9] HE M, GAO L, ZHANG S, et al.Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL[J]. Gastric Can-cer:Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014, 17(3):431-441.
[10] HUI WT, MA XB, ZAN Y, et al.Prognostic significance of MiR-34a expression in patients with gastric cancer after radical gastrectomy[J].Chinese Medical Journal, 2015, 128(19):2632-2637.
[11] Wong M Y, Yu Y, Walsh W R, et al.MicroRNA-34 family and treatment of cancers with mutant or wild-type p53(review)[J].International Journal of Oncology, 2011, 38(5):1189.
[12] Tscherner A, Gilchrist G, Smith N, et al.MicroRNA-34 family expression in bovine gametes and preimplantation embryos[J].Reprod Biol Endocrinol, 2014, 12(1):1-9.
[13] HU Y, PU Q, CUI B, et al.MicroRNA-34a inhibits tumor invasion and metastasis in gastric cancer by targeting Tgif2[J].International Journal of Clinical & Experimental Pathology, 2015, 8(8):8921-8928.
[14] LIN X, XU X Y, CHEN Q S, et al.Clinical significance of microRNA-34a in esophageal squamous cell carcinoma[J].Genetics & Molecular Research Gmr, 2015, 14(4):17684.
[15] Adams B D, Parsons C, Slack F J.The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas[J].Expert Opinion on Therapeutic Targets, 2016, 20(6):737-753.
[16] Nugent M, Miller N, Kerin M J.Circulating miR-34a levels are reduced in colorectal cancer[J].Journal of Surgical Oncology, 2012, 106(8):947-952.
[17] YAO Y, SUO A L, LI Z F, et al.MicroRNA profiling of human gastric cancer[J]. Molecular Medicine Reports, 2009, 2(6):963.
[18] Sukata T, Sumida K, Kushida M, et al.Circulating micro-RNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages[J].Toxicology Letters, 2011, 200(1):46-52.
[19] Tsai K W, Leung C M, Lo Y H, et al.Arm selection prefe-rence of MicroRNA-193a varies in breast cancer[J].Scientific Reports, 2016, 6:28176.

相似文献/References:

[1]李小牛.王道坤教授治疗胃癌临床经验[J].甘肃中医药大学学报,2008,(01):4.
[2]李群星,方海洋.真核细胞起始因子4E与胃癌中医证型关系的研究[J].甘肃中医药大学学报,2009,(06):20.
 Li Qunxing,Fang Haiyang.Study of the relationship between eIF4E and Chinese medical syndromes of gastric cancer[J].Journal of Gansu University of Chinese Medicine,2009,(06):20.
[3]杨林,王晓鹏,罗慧英.环氧化酶-2与血管内皮生长因子-C在胃癌中的表达及相关性研究进展[J].甘肃中医药大学学报,2014,31(03):115.

备注/Memo

备注/Memo:
收稿日期:2018-08-21。
基金项目:甘肃省高等学校科研项目(甘财教[2014]63-15);甘肃省高等学校科研项目(2016A-045)。
作者简介:魏丽琼(1983-),女,主治医师,医学硕士,主要从事儿童保健工作。
通信作者:刘月芬(1964-),女,主任医师,医学硕士,主要从事儿童保健工作。E-mail:liuyuefen88@163.com
更新日期/Last Update: 1900-01-01